Ross JS - Search Results

1

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, Donahue A, Downing SR, Frampton GM, Garcia L, Juhn F, Mitchell KC, White E, White J, Zwirko Z, Peretz T, Nechushtan H, Soussan-Gutman L, Kim J, Sasaki H, Kim HR, Park SI, Ercan D, Sheehan CE, Ross JS, Cronin MT, Jänne PA, Stephens PJ. Lipson D, et al. Among authors: ross js. Nat Med. 2012 Feb 12;18(3):382-4. doi: 10.1038/nm.2673. Nat Med. 2012. PMID: 22327622 Free PMC article.

2

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.

Tran TA, Kallakury BV, Sheehan CE, Ross JS. Tran TA, et al. Among authors: ross js. Hum Pathol. 1997 Jul;28(7):809-14. doi: 10.1016/s0046-8177(97)90154-4. Hum Pathol. 1997. PMID: 9224749

3

Prognostic factors in gastric cancer.

Brien TP, Depowski PL, Sheehan CE, Ross JS, McKenna BJ. Brien TP, et al. Among authors: ross js. Mod Pathol. 1998 Sep;11(9):870-7. Mod Pathol. 1998. PMID: 9758367

4

Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer.

Depowski PL, Brien TP, Sheehan CE, Stylos S, Johnson RL, Ross JS. Depowski PL, et al. Among authors: ross js. Am J Clin Pathol. 1999 Oct;112(4):459-69. doi: 10.1093/ajcp/112.4.459. Am J Clin Pathol. 1999. PMID: 10510669

5

Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.

Kallakury BV, Sheehan CE, Ross JS. Kallakury BV, et al. Among authors: ross js. Hum Pathol. 2001 Aug;32(8):849-55. doi: 10.1053/hupa.2001.26463. Hum Pathol. 2001. PMID: 11521230

6

Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer.

Rosenthal SI, Depowski PL, Sheehan CE, Ross JS. Rosenthal SI, et al. Among authors: ross js. Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):40-6. doi: 10.1097/00129039-200203000-00007. Appl Immunohistochem Mol Morphol. 2002. PMID: 11893034

7

Morphologic and molecular prognostic markers in prostate cancer.

Ross JS, Sheehan CE, Dolen EM, Kallakury BV. Ross JS, et al. Adv Anat Pathol. 2002 Mar;9(2):115-28. doi: 10.1097/00125480-200203000-00003. Adv Anat Pathol. 2002. PMID: 11917165 Review.

8

Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.

Ross JS, Kaur P, Sheehan CE, Fisher HA, Kaufman RA Jr, Kallakury BV. Ross JS, et al. Mod Pathol. 2003 Mar;16(3):198-205. doi: 10.1097/01.MP.0000056984.62360.6C. Mod Pathol. 2003. PMID: 12640098

9

Survivin and Bcl-2 expression in prostatic adenocarcinomas.

Kaur P, Kallakury BS, Sheehan CE, Fisher HA, Kaufman RP Jr, Ross JS. Kaur P, et al. Among authors: ross js. Arch Pathol Lab Med. 2004 Jan;128(1):39-43. doi: 10.5858/2004-128-39-SABEIP. Arch Pathol Lab Med. 2004. PMID: 14692814 Free article.

10

Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.

Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA, Ross JS. Goncharuk VN, et al. Among authors: ross js. Ann Diagn Pathol. 2004 Feb;8(1):6-16. doi: 10.1016/j.anndiagpath.2003.11.002. Ann Diagn Pathol. 2004. PMID: 15129904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,633 results

Search Page